By Andrew S. Krulwich, a partner in the Washington, D.C. law firm Wiley Rein & Fielding LLP, argues that the Food and Drug Administration cannot legally force a prescription drug maker to offer it’s product “over-the-counter” and should not do so for sound public policy reasons.